Holdings (as at 2025-11-06)
Percentage of net assets may not equal 100%
Security Name % of Net Assets
Insmed Incorporated 2.85%
Incyte Corporation 2.74%
Regeneron Pharmaceuticals, Inc. 2.54%
Medpace Holdings, Inc. 2.54%
Ionis Pharmaceuticals, Inc. 2.50%
Biogen Inc. 2.47%
Universal Health Services, Inc. (Class B) 2.45%
United Therapeutics Corporation 2.39%
Centene Corporation 2.30%
Illumina, Inc. 2.25%
Pfizer Inc. 2.15%
BioMarin Pharmaceutical Inc. 2.11%
Avantor, Inc. 2.00%
Tempus AI, Inc. (Class A) 1.97%
Neurocrine Biosciences, Inc. 1.95%
HCA Healthcare, Inc. 1.95%
Globus Medical, Inc. (Class A) 1.90%
Elanco Animal Health Incorporated 1.89%
Merck & Co., Inc. 1.81%
Acadia Healthcare Company, Inc. 1.81%
Elevance Health Inc. 1.72%
Molina Healthcare, Inc. 1.70%
Alnylam Pharmaceuticals, Inc. 1.70%
Abbott Laboratories 1.65%
Halozyme Therapeutics, Inc. 1.65%
Zimmer Biomet Holdings, Inc. 1.59%
Teleflex Incorporated 1.57%
The Cigna Group 1.57%
Royalty Pharma Plc (Class A) 1.53%
Doximity, Inc. (Class A) 1.51%
IDEXX Laboratories, Inc. 1.48%
Bio-Rad Laboratories, Inc. (Class A) 1.45%
Align Technology, Inc. 1.41%
Henry Schein, Inc. 1.40%
Bristol-Myers Squibb Company 1.37%
Johnson & Johnson 1.34%
Tenet Healthcare Corporation 1.33%
Exelixis, Inc. 1.31%
GE HealthCare Technologies Inc. 1.31%
Veeva Systems Inc. (Class A) 1.29%
Humana Inc. 1.28%
UnitedHealth Group Incorporated 1.24%
Quest Diagnostics Incorporated 1.23%
Cardinal Health, Inc. 1.11%
Organon & Co. 1.11%
Gilead Sciences, Inc. 0.98%
Hologic, Inc. 0.97%
Insulet Corporation 0.92%
Revvity, Inc. 0.90%
Sotera Health Company 0.90%
Perrigo Company Plc 0.89%
The Cooper Companies, Inc. 0.89%
QIAGEN N.V. 0.85%
Chemed Corporation 0.85%
Becton, Dickinson and Company 0.84%
AbbVie Inc. 0.84%
Medtronic Plc 0.83%
ResMed Inc. 0.81%
Corcept Therapeutics Inc. 0.78%
Apellis Pharmaceuticals, Inc. 0.77%
Waters Corporation 0.51%
Exact Sciences Corporation 0.51%
Natera, Inc. 0.51%
Thermo Fisher Scientific Inc. 0.48%
Agilent Technologies, Inc. 0.48%
Amgen Inc. 0.46%
IQVIA Holdings Inc. 0.46%
Edwards Lifesciences Corporation 0.44%
Penumbra, Inc. 0.43%
Steris Plc 0.43%
Envista Holdings Corporation 0.40%
Sarepta Therapeutics, Inc. 0.38%
Encompass Health Corporation 0.37%
Labcorp Holdings Inc. 0.36%
Zoetis Inc. 0.34%
Baxter International Inc. 0.33%

Holdings are subject to change.

Commissions, management fees and expenses all may be associated with Exchange-Traded Fund investments. Please carefully read the prospectus of the fund before investing. Exchange-Traded funds are not guaranteed, their values change frequently and past performance may not be repeated.